Speech-Language Pathologists in Laurel, MT Accepting Medicare
4 Speech-Language Pathologists found. Showing 1 - 4
 Meagan L Kimmel, M.S. CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 820 3rd Ave, Laurel, MT 59044 Phone: 406-628-8251 |
Jaime Nelson Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 820 3rd Ave, Laurel, MT 59044 Phone: 406-281-2818 |
Suzanne P. Bender, STP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 820 3rd Ave, Laurel, MT 59044 Phone: 406-628-8251 Fax: 406-628-8253 |
Janis E. Hayes-strom, SP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 820 3rd Ave, Laurel, MT 59044 Phone: 406-628-8251 Fax: 406-628-8253 |
News Archive
Food insufficiency, impulsivity, drinking, and childhood trauma related to IPV perpetration
Intimate partner violence (IPV) – commonly known as domestic violence, and long associated with drinking – is a significant public health problem.
Nanoparticle injections may help prevent cartilage degeneration in osteoarthritis patients
Osteoarthritis is a debilitating condition that affects at least 27 million people in the United States, and at least 12 percent of osteoarthritis cases stem from earlier injuries.
FDA issues warning letters to companies illegally selling unapproved CBD products
Today, the U.S. Food and Drug Administration issued five warning letters to companies for selling products containing cannabidiol (CBD) in ways that violate the Federal Food, Drug, and Cosmetic Act (FD&C Act).
Scientists identify new way to accelerate ion beams for improving cancer treatment
A group of researchers at Chalmers University of Technology has discovered a completely new way of using lasers to accelerate ion beams.
ZIOPHARM Oncology commences Phase I/II study of Zybulin for metastatic breast cancer
ZIOPHARM Oncology, Inc., announced today it has initiated a Phase I/II study at Memorial Sloan-Kettering Cancer Center for the novel, mathematically - determined administration of oral indibulin (Zybulin™ or ZIO-301) in the treatment of metastatic breast cancer.
› Verified 7 days ago
Chiropractors
Physical Therapists
Occupational Therapists
Optometrists
Speech-Language Pathologists